NCT01821677View on ClinicalTrials.gov

A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.

PHASE2CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

February 26, 2013

Primary Completion Date

October 30, 2014

Study Completion Date

January 23, 2015

Conditions
Diabetic Macular Edema
Interventions
DRUG

Danazol Capsules

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT01821677 - A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema. | Biotech Hunter | Biotech Hunter